Latest Bluglass (ASX:BLG) News

BluGlass has agreed an A$8.0 million R&D-backed loan with Rockford, refinancing its existing Radium facility and adding about A$5.5 million of liquidity. The funding gives the laser developer more room to scale, but carries a 16.5% interest rate and repayment obligations tied to future tax refunds.

BluGlass has begun a three-to-five-month, A$286,000 feasibility collaboration with global photonics company Coherent to develop a novel gallium nitride device for scientific and medical applications. The agreement offers technical and commercial promise, but does not yet include a production commitment or confirmed product launch.

Small technology shares delivered a mixed week, with Cycliq and Identitii leading the biggest reported gains while several companies fell despite new deals or technical progress.
Investors rewarded stronger cash results, but continued to question losses, new share issues and early-stage projects.

BluGlass Limited reported a 5% reduction in its net loss to A$10.39 million for FY26 despite a 10% revenue dip, boosted by new US defence and industry contracts and a significant capital raise to fund growth.

Appen led the technology market with a 45.73% weekly rise, while Synertec and InteliCare also gained more than 27%.
AI services, defence systems, critical infrastructure and recurring software revenue drove the week’s strongest company updates.

BluGlass capped FY26 with major contract wins including a $1.4 million Phase II deal with Uviquity, a $1.3 million agreement with a Fortune 500 data storage giant, and a world-record 1.9W output from its blue GaN laser, while raising $14.6 million to fuel growth.

Small-cap tech trading split into two clear camps this week: profit-backed winners and capital-raising laggards. Big contracts, rising recurring revenue and a major takeover kept money flowing into selected names.

BluGlass has landed a A$1.4 million Phase II deal with Uviquity, extending their collaboration on cutting-edge photonic integrated circuits and visible GaN lasers.

AI infrastructure names drove the biggest moves this week, with DXN exploding higher and Stakk extending its run after a new US healthcare contract. Elsewhere, capital raisings, takeover moves and executive changes kept tech investors busy, while several early gap-ups faded as buying cooled.

BluGlass has locked in a $1 million firm commitment through an option shortfall agreement, with potential to raise $1.5 million, reinforcing its financial position after an upsized $8 million placement. The funds will accelerate GaN laser contract delivery and working capital.

Small-cap tech money chased clear revenue stories, AI products and contract wins this week. The biggest moves came from Xref and ION Video, while BluGlass fell after tapping investors for fresh cash.

BluGlass has secured an upsized A$8 million placement, including a A$2.3 million cornerstone investment from its board and management, to accelerate its gallium nitride laser manufacturing and support a growing project pipeline.